Supporting Eye Injection Treatment Adherence in Singapore
Part of Eyes & vision clinical trials.
This study tests whether a coordinated team approach can help patients stick with regular eye injections for conditions like age-related macular degeneration and diabetic eye disease. Researchers want to see if extra support and planning improve how often patients complete their recommended treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have a chronic eye condition (age-related macular degeneration or diabetic eye disease) that needs regular eye injections
- Be willing and able to receive eye injections at the study visit
- Speak English or Mandarin fluently
- Live in Singapore
- Be able to complete a brief computer-based questionnaire and work with a support team
- Have no other serious eye problems (like cornea damage, glaucoma, or other retinal diseases) that could affect your vision
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether specially trained nurses can safely give eye injections instead of doctors. It may make treatment quicker and easier for people who need regular injections for eye conditions.
This trial tests a new injection medicine (AIV007) placed around the eye to treat wet age-related macular degeneration (a condition that damages central vision). You may qualify if you've been treated for this condition before and responded well to previous eye injections.
This Phase 3 study compares a new eye injection (RC28-E) with the standard treatment (aflibercept) for diabetic macular edema, which is swelling in the central retina that affects vision. It aims to see whether the new treatment works as well and is safe.
This study tests different doses of a new medicine (BI 3812465) injected into the eye to treat diabetic macular edema—swelling in the back of the eye caused by diabetes that can blur vision. The trial measures how safe the medicine is and how well patients tolerate it.
This study compares two different eye injection treatments for diabetic macular edema (DME)—a condition where fluid builds up in the center of the retina, blurring vision. Researchers want to see how certain measures in the blood and in eye scans relate to how well each treatment works.
This study tests a new drug (RO7823653) given as an eye injection for people with diabetic macular edema, a condition where swelling in the retina harms vision. It aims to see if the drug is safe and how the body processes it.
Hear when a new Diabetic Macular Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.